I Dalifard
Overview
Explore the profile of I Dalifard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riedinger J, Eche N, Basuyau J, Dalifard I, Hacene K, Pichon M
Gynecol Oncol
. 2008 Mar;
109(2):194-8.
PMID: 18329083
Background: CA 125 assays enable treatment-response monitoring in ovarian cancer. Methods: A multicentric study of CA 125 kinetics under paclitaxel/platinum-based chemotherapy was performed in 130 stage IIc-IV patients. CA 125...
2.
Riedinger J, Bonnetain F, Basuyau J, Eche N, Larbre H, Dalifard I, et al.
Ann Oncol
. 2007 Feb;
18(5):881-5.
PMID: 17301071
Background: CA 125 assays enable treatment response monitoring in ovarian cancer. Patients And Methods: This multicentric study was carried out to assess the prognostic value of the CA 125 change...
3.
Riedinger J, Wafflart J, Ricolleau G, Eche N, Larbre H, Basuyau J, et al.
Ann Oncol
. 2006 Jun;
17(8):1234-8.
PMID: 16766592
Background: CA 125 assays enable treatment-response monitoring in ovarian cancer. Patients And Methods: A multicentric study of CA 125 kinetics under induction chemotherapy was performed in 631 patients. CA 125...
4.
Dalifard I, Daver A, Larra F
Anticancer Res
. 2000 Mar;
19(6B):5015-22.
PMID: 10697504
Mutations of the TP53 gene induce the production of an abnormal protein (p53) with a prolonged half-life allowing its detection by monoclonal antibodies and leading to a development of serum...
5.
Dalifard I, Daver A, Goussard J, Lorimier G, Lortholary A, Larra F
Int J Mol Med
. 1998 Dec;
1(5):855-61.
PMID: 9852307
In breast cancer, DNA amplification of the oncogene c-erbB-2, encoding for the p185 protein, is associated with a poor prognosis. A retrospective study on a population of 220 cases of...
6.
BESSE G, Kwiatkowski F, Gaillard G, Daver A, Dalifard I, Basuyau J, et al.
Bull Cancer
. 1994 Apr;
81(4):289-96.
PMID: 7703545
pS2 protein assay was performed with Elsa-pS2 kit (CIS-Biointernational) on a group of 1,065 patients with operable breast cancer who underwent breast surgery in the years 1982 through 1990. The...
7.
Daver A, Dalifard I, Krebs B, Gosselin P, Cazin J, Ricolleau G, et al.
Bull Cancer
. 1990 Jan;
77(8):781-92.
PMID: 2207367
A multicenter and retrospective study of the diagnosis value of SCC-TA4 in squamous cell carcinomas of 4 localisations was made with the 2 thresholds of 2 and 2.5 ng/ml. However,...
8.
Bocquillon P, Daver A, Page M, Dalifard I, Chassevent A, Cellier P, et al.
Bull Cancer
. 1989 Jan;
76(3):291-300.
PMID: 2736315
We report a flow cytometric study on ploidy in 117 colorectal cancers. An aneuploid cell population was found in more than 70% of adenocarcinomas. Ploidy was found to be stage-related;...
9.
Daver A, Bocquillon P, Page M, Dalifard I, Chassevent A, Litas P, et al.
Anticancer Res
. 1987 May;
7(3 Pt B):531-4.
PMID: 3631913
The results are reported of cytofluorometric DNA analyses of colorectal tumors using cells obtained by mechanical disruption and fine needle aspiration. The latter method does not lower the level of...
10.
Page M, Dalifard I, Bertrand G, Bocquillon P, Daver A
Anticancer Res
. 1986 Sep;
6(5):893-6.
PMID: 3541780
Carcinoembryonic antigen was measured in serum and in extracts from 37 colorectal tumors and we found a poor correlation between circulating and tumor CEA. Monoclonal antiCEA antibodies were used in...